{
    "Trade/Device Name(s)": [
        "ADVIA Centaur\u00ae Calcitonin (CALCT) assay"
    ],
    "Submitter Information": "Axis-Shield Diagnostics Limited",
    "510(k) Number": "K182012",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132828"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKR"
    ],
    "Summary Letter Date": "November 29, 2018",
    "Summary Letter Received Date": "December 3, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1140"
    ],
    "Regulation Name(s)": [
        "Calcitonin test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Calcitonin"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [
        "Serum separator tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur XP system"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)",
        "Automated immunoassay"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Calcitonin (CALCT) automated CMIA assay for quantitative measurement of calcitonin in human serum.",
    "Indications for Use Summary": "In vitro diagnostic use for quantitative measurement of calcitonin in human serum as an aid in the diagnosis and treatment of diseases involving the thyroid and parathyroid glands, including carcinoma and hyperparathyroidism.",
    "fda_folder": "Clinical Chemistry"
}